RECRUITINGOBSERVATIONAL
Treatment Outcomes of Esophageal Cancer
About This Trial
This study will be a carried out through a prospective observational cohort design in conjunction with researchers in the African Esophageal Cancer Consortium (AfrECC). The purpose of this research is to prospectively evaluate outcomes related to existing treatment strategies for esophageal cancer (EC) at participating sites within AfrECC.
Who May Be Eligible (Plain English)
Who May Qualify:
- Participants with histopathologically confirmed or presumptive clinical diagnosis of EC. For patients who do not have histopathologically confirmed disease, presumptive clinical diagnosis may be based upon barium swallow or endoscopy without biopsy.
- Age 18 years of age or older;
Who Should NOT Join This Trial:
- Unable to provide willing to sign a consent form
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Participants with histopathologically confirmed or presumptive clinical diagnosis of EC. For patients who do not have histopathologically confirmed disease, presumptive clinical diagnosis may be based upon barium swallow or endoscopy without biopsy.
* Age 18 years of age or older;
Exclusion Criteria:
* Unable to provide informed consent
Treatments Being Tested
OTHER
Assessment of patient-reported outcomes (PROs)
Questionnaires will be administered to participants
Locations (6)
Tenwek Hospital
Bomet, Kenya
Moi Teaching and Referral Hospital
Eldoret, Kenya
Kamuzu Central Hospital
Lilongwe, Malawi
Muhimbili National Hospital
Dar es Salaam, Tanzania
Ocean Road Cancer Institute
Dar es Salaam, Tanzania
Kilimanjaro Christian Medical Centre
Moshi, Tanzania